BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang J, Chen H, Chen C, Liu H, He Y, Zhao J, Yang P, Mao Q, Xia H. Systemic administration of mesenchymal stem cells loaded with a novel oncolytic adenovirus carrying IL-24/endostatin enhances glioma therapy. Cancer Lett 2021;509:26-38. [PMID: 33819529 DOI: 10.1016/j.canlet.2021.03.027] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Wu Z, Bian Y, Chu T, Wang Y, Man S, Song Y, Wang Z. The role of angiogenesis in melanoma: Clinical treatments and future expectations. Front Pharmacol 2022;13:1028647. [PMID: 36588679 DOI: 10.3389/fphar.2022.1028647] [Reference Citation Analysis]
2 Chen X, Wang Y, Liu H, Zhang J, Wang J, Jin X, Ma Y. CSP I-plus modified rEndostatin inhibits hepatocellular carcinoma metastasis via down-regulation of VEGFA and integrinβ1. BMC Cancer 2022;22:1200. [PMID: 36419008 DOI: 10.1186/s12885-022-10318-8] [Reference Citation Analysis]
3 Zhang T, Lin R, Wu H, Jiang X, Gao J. Mesenchymal stem cells: A living carrier for active tumor-targeted delivery. Adv Drug Deliv Rev 2022;185:114300. [PMID: 35447165 DOI: 10.1016/j.addr.2022.114300] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Keshavarz M, Mohammad Miri S, Behboudi E, Arjeini Y, Dianat-Moghadam H, Ghaemi A. Oncolytic virus delivery modulated immune responses toward cancer therapy: Challenges and perspectives. Int Immunopharmacol 2022;108:108882. [PMID: 35623296 DOI: 10.1016/j.intimp.2022.108882] [Reference Citation Analysis]
5 Zhang Q, Li Y, Fender P, Yu B, Feng L, Chen L, Yu X. Editorial: Adenoviral Infection and Immunity, and Adenoviral Vectors for Gene Therapy Applications. Front Microbiol 2022;13:869059. [DOI: 10.3389/fmicb.2022.869059] [Reference Citation Analysis]
6 Attia N, Mashal M, Pemminati S, Omole A, Edmondson C, Jones W, Priyadarshini P, Mughal T, Aziz P, Zenick B, Perez A, Lacken M. Cell-Based Therapy for the Treatment of Glioblastoma: An Update from Preclinical to Clinical Studies. Cells 2021;11:116. [PMID: 35011678 DOI: 10.3390/cells11010116] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Wang Y, Sheng J, Chai J, Zhu C, Li X, Yang W, Cui R, Ge T. Filamentous Bacteriophage-A Powerful Carrier for Glioma Therapy. Front Immunol 2021;12:729336. [PMID: 34566987 DOI: 10.3389/fimmu.2021.729336] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]